Barbara A. Binzak Blumenfeld
Barbara A. Binzak BlumenfeldShareholder,
Buchanan Ingersoll & Rooney PC

Barbara A. Binzak Blumenfeld, Ph.D., focuses her legal practice on clients whose products are subject to U.S. Food and Drug Administration (FDA) regulations, including drugs, biologics, medical devices, foods, dietary supplements, medical foods, and cosmetics. She advises clients on a wide variety of development and approval issues including requirements for new drug applications (NDAs), abbreviated new drug applications (ANDAs), over-the-counter (OTC) drug monographs and drug labeling, investigational new drug application (IND) and biologics license application (BLA) requirements for biologic products, such as stem cells and regulation of human cells, tissues, and cellular and tissue-based products (HCT/Ps).

Prior to law school, Barbara earned her Ph.D. in molecular biology, focusing her research on the study of genes encoding proteins involved in amino acid and lipid metabolism. She also earned a dual J.D./M.A. degree in biomedical ethics following her Ph.D.

© Copyright 2019 Legal Media Group. All Rights Reserved.